Peptide blood work guide

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Before starting peptides, it's important to get blood tests to see your current health status and make sure the treatment is safe and effective for you. After starting, we'll recheck your blood to see how your body is responding and adjust your plan as needed.

Understanding Your Peptide Blood Work Results

When you're optimizing your health with peptides, understanding your blood work isn't just helpful; it's essential for safety and efficacy. We often see patients who are eager to start a peptide protocol but haven't considered the baseline measurements that will guide their journey. Without these markers, you're essentially flying blind.

The primary goal of pre- and post-peptide blood work is to establish a baseline, monitor your body's response, and ensure you're not inadvertently creating imbalances. Unlike a simple "before and after" photo, blood tests give us objective data on what's happening inside.

Key Markers to Monitor Before Starting Peptides

Before initiating most peptide protocols, especially those involving growth hormone secretagogues like CJC-1295 or Ipamorelin, we always recommend a comprehensive panel. This isn't just about the peptide itself; it's about your overall health picture.

What to Look For in Follow-Up Blood Work

Typically, we'll re-evaluate your blood work 8-12 weeks into a peptide protocol. This allows enough time for the peptides to exert their effects and for your body to adapt.

The most significant change we often look for with GH secretagogues is an increase in IGF-1. We aim for a healthy, physiological increase, not an excessively high one, which could indicate overstimulation. For example, if your baseline IGF-1 was 150 ng/mL, we'd be pleased to see it rise to 250 ng/mL. If it jumps to 400 ng/mL, we might consider adjusting the dosage.

We're also monitoring for any adverse shifts in your glucose, HbA1c, or lipid panel. While rare with appropriate dosing, some individuals might experience a slight increase in fasting glucose due to GH's counter-regulatory effects on insulin. If this occurs, we can adjust the peptide dosage or recommend dietary modifications.

Nuances and Individual Variability

It's important to remember that everyone responds differently. Two individuals on the exact same peptide protocol might show different IGF-1 responses. This isn't necessarily a sign of failure; it simply means their physiology is unique. Factors like age, diet, exercise, sleep quality, and underlying health conditions all play a role in how your body utilizes peptides.

For instance, an older individual with significantly lower baseline GH production might see a more dramatic percentage increase in IGF-1 than a younger person with already adequate levels. That's why the baseline is so critical.

Unlike simply taking a supplement and hoping for the best, peptide therapy is a more targeted approach. The blood work provides objective feedback, allowing us to fine-tune your protocol for optimal results and safety. Don't skip this crucial step; it's your roadmap to success.